Major depressive disorder Trials in Atlanta, United States
Conditions / Major depressive disorder / Atlanta, United States
Clinical trials for Major depressive disorder investigate a range of treatment strategies and patient populations.
145 total trials for this combination
Showing top 10 of 145 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03288714 | Adaptive Design Study of NEST sTMS in Subjects With Major Depressive Disorder | COMPLETED | NA |
| NCT01153347 | A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT01085812 | Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT04039022 | Open-Label Safety Study of AXS-05 in Subjects With Depression | COMPLETED | PHASE3 |
| NCT00278941 | Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT04019704 | A Trial of AXS-05 in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT06029439 | Study to Assess the Safety and Effectiveness of NMRA-335140-501 | RECRUITING | PHASE3 |
| NCT01436175 | SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study | TERMINATED | PHASE3 |
| NCT02669030 | A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual Insomnia | UNKNOWN | PHASE4 |
| NCT05859698 | Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia | COMPLETED | PHASE4 |